Famotidine For Suspension
Product Images NDC 27241-249

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 27241-249). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40mg (Famotidine Label)

This label panel for Famotidine for Oral Suspension, USP 40 mg/5 mL displays preparation directions, storage conditions, and usage warnings. It instructs reconstitution with 46 mL water and shaking, storage between 20°C to 25°C, and discarding unused suspension after 30 days. The label includes marketing and manufacturing details from Ajanta Pharma USA Inc.*

FDA Label Image

Structure (Famotidine Structure)

Chemical structure diagram of famotidine, showing its molecular components and arrangement as labeled in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.